What is IBI-Ag?
Established in 2017, IBI-Ag is at the forefront of discovering and developing novel biological solutions for insect control, leveraging environmentally friendly technology. The company's breakthrough approach focuses on producing efficient, selective, and safe bio-insect control agents. IBI-Ag's technology is designed to be highly cost-effective, particularly due to its suitability for fermentation processes, enabling farmers to reduce production costs for agricultural produce. The company operates within the burgeoning agritech sector, addressing the growing demand for sustainable pest management alternatives.
How much funding has IBI-Ag raised?
IBI-Ag has raised a total of $16.1M across 2 funding rounds:
Other Financing Round
$6.1M
Series A
$10M
Other Financing Round (2025): $6.1M with participation from The Trendlines Group and Corteva Agriscience
Series A (2025): $10M led by Consensus Business Group, Corteva Agriscience, The Trendlines Group, and Iron Nation
Key Investors in IBI-Ag
Consensus Business Group
Consensus Business Group is a UK-based investor focused on residential ground rents, though their participation here suggests a broader interest in innovative ventures. Their involvement in IBI-Ag's funding round indicates a potential diversification into the agritech sector.
Corteva Agriscience
Corteva Agriscience is a major global player in the agriculture business, offering seed and crop protection solutions. Their investment in IBI-Ag highlights a strategic interest in complementary biological pest control technologies that align with their existing portfolio and commitment to sustainable farming practices.
The Trendlines Group
The Trendlines Group is an investment company dedicated to agrifood and medtech innovations. As hands-on investors, they actively support portfolio companies in technology development and business building, indicating a strategic partnership aimed at advancing IBI-Ag's bio-insect control solutions.
What's next for IBI-Ag?
The substantial enterprise-level funding and recent strategic investment indicate that IBI-Ag is poised for significant expansion and further research and development. This capital infusion is expected to accelerate the commercialization of its bio-insect control products, enhance its production capabilities, and broaden its market reach. The involvement of strategic partners like Corteva Agriscience and Consensus Business Group suggests a strong validation of IBI-Ag's technology and market potential, positioning the company for future growth and impact in sustainable agriculture.
See full IBI-Ag company page
